IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF SURVIVAL OUTCOMES AND ADVERSE EVENTS. Frontier in Medical and Health Research, [S. l.], v. 4, n. 5, p. 871–886, 2026. Disponível em: https://fmhr.net/index.php/fmhr/article/view/2945.. Acesso em: 28 jul. 2026.